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TO THE EDITOR 
The inhibition of unwanted hair growth (hirsutism, hypertrichosis) by safe, but 
effective agents that do not destroy the hair follicle (HF) remains an important 
challenge in clinical dermatology. Being interested in identifying alternative therapies 
to depilation, laser therapy, anti-androgens and eflornithine (Blume-Peytavi, 2013), 
we explored whether modulating peroxisome proliferator-activated receptors (PPARγ, 
α, and /δ), namely PPARγ, may provide a promising novel strategy for the inhibition 
of excessive human hair growth. 
As part of the nuclear receptor super-gene family, PPARs control the expression of 
genes which regulate inflammation and lipid metabolism (s8, s15). Activation of all 
three PPARs alters the expression of inflammatory mediators including cytokines, 
receptors and adhesion molecules, thereby exhibiting an overall strong anti-
inflammatory effect (Choi and Bothwell, 2012). Moreover, PPARγ activation 
stimulates keratinocyte and sebocyte differentiation as well as epidermal lipid 
synthesis and regulates epidermal barrier homeostasis (s4, s12). From a hair growth 
perspective, PPARγ agonists are particularly interesting since PPARγ-signaling is 
required for the maintenance of HF epithelial stem cells in mice, while insufficient 
PPARγ-signaling may predispose patients to develop the inflammatory cicatricial 
alopecia, lichen planopilaris (LPP) (Karnik et al., 2009, s2), even though the 
occurrence of individual LPP lesions may not be PPARγ-driven (Harries et al., 2013).  
Hence, PPAR agonists are interesting from a hair and stem cell biology perspective 
as well as in scarring alopecia. Additionally, given that there is growing interest in 
producing selective PPARγ modulators that retain the desirable therapeutic activities 
without the unwanted effects (Higgins and Depaoli, 2010), we tested the hair growth-
modulatory effects of a newly designed anti-inflammatory PPARγ modulator, GMG-
43AC, a new chemical entity with structural similarity to propionic acid, with a 
favorable toxicological profile (Pirat et al., 2012) and documented selective action as 
a PPAR-modulator (see Supplementary Text and Supplementary Figure S1a-c).  
This was studied in microdissected, organ-cultured female human scalp HFs 
(Kloepper et al., 2010), while potential anti-inflammatory effects of GMG-43AC 
were assessed in normal human keratinocytes (NHKs) exposed to defined 
inflammatory stimuli. 
Measurement of lactate dehydrogenase (LDH) levels in the HF organ culture 
supernatants showed only a slight increase in LDH activity by day 6 (Supplementary 
Figure S2a), suggesting only low-level GMG-43AC-associated general tissue toxicity. 
While administration of GMG-43AC for 6 days did not alter hair shaft elongation 
(Supplementary Figure S2b), HF cycle analyses revealed that all tested GMG-43AC 
doses strongly decreased the percentage of HFs in anagen, and induced premature HF 
regression (catagen development) (Figure 1a): while only 55% of the HFs treated with 
vehicle transformed into the catagen phase after 6 days, almost all (85%) of the 
0.01mM GMG-43AC-treated HFs were in this phase. In the two higher doses of 
GMG-43AC, 70% of HFs were in the catagen phase. These results were 
independently confirmed by measuring the hair cycle score (s3), which reached 
significance in the 0.01 mM dose (Figure 1b), supporting catagen promotion. While 
GMG-43AC did not significantly alter the percentage of proliferating hair matrix 
keratinocytes in anagen VI HFs, GMG-43AC tended to stimulate keratinocyte 
apoptosis in the hair matrix (significance reached at 0.1 mM) (Supplementary Figure 
S2c).  
Since PPARγ-mediated signaling is important for the maintenance of murine HF 
epithelial stem cells and is defective in human LPP patients (Karnik et al., 2009) we 
also explored whether GMG-43AC modulates in situ the expression of two signature 
keratins that are up-regulated by human HF progenitor cells, i.e. keratins K15 and 
K19 (Kloepper et al., 2008; Lyle et al., 1998; Michel et al., 1996). Interestingly, 
GMG-43AC significantly upregulated K15-immunoreactivity in all tested doses 
(Figure 1c), but did not significantly alter the number of K15-positive cells (Figure 
1c). A positive impact on human HF epithelial progenitor cells was independently 
corroborated by demonstrating that K19-immunoreactivity was also significantly 
upregulated by GMG-43AC (Figure 1d). This PPARγ-modulator also elevated the 
relative number of K19-positive cells in the lower outer root sheath (Figure 1d). These 
observations suggest that GMG-43AC may effectively inhibit unwanted human hair 
growth by inducing catagen while simultaneously preserving (or possibly even 
promoting) the HF’s epithelial progenitor cell pools. 
As a first attempt towards identifying early-response candidate target genes of GMG-
43AC-mediated stimulation, two independent sets of organ-cultured female human 
scalp HFs were compared by genome-wide DNA microarray analysis (see 
Supplementary Text). This identified 39 genes as being substantially upregulated (i.e. 
>3 fold, p<0.05) in the HFs of both female patients investigated by stimulation with 
0.01 mM GMG-43AC for 6 hours (Supplementary Table S1). Among these 
upregulated genes, none was a gene recognized to be specific for epithelial HF stem 
cells. However, COL6A1, which encodes the alpha 1 chain of collagen VI, is known 
to be expressed in very close proximity to the HF (Watson et al., 2001) and may be 
involved in HF development during embryogenesis (Smith, 1994). Therefore, we 
validated this maximally regulated gene by quantitative RT-PCR, which 
independently confirmed that 0.01 mM GMG-43AC significantly increased COL6A1 
mRNA expression (Supplementary Figure S2d). While the mechanisms that underlie 
the observed HF and HF stem cell effects of GMG-43AC remain to be systematically 
dissected, the current microarray analysis has at least identified some candidate early-
response target genes (for extended discussion of microarray results, see legend of 
Supplementary Table S1).  
Since PPAR activation is known to elicit an anti-inflammatory response (Choi and 
Bothwell, 2012), we finally investigated the effect of GMG-43AC on mRNA 
expression and protein secretion of interleukin (IL)-6 in NHKs treated with interferon 
(IFN)- or tumor necrosis factor (TNF)-α. As expected, treatment of NHKs with IFN-
 (30 ng/ml) or TNF-α (10 ng/ml) for 6 h markedly increased the mRNA level as well 
as the released amount of IL-6, while co-administration of GMG-43AC prevented the 
above effects both at the mRNA (Figure 2a,b) and protein levels (Figure 2c,d). 
Notably, no significant change in the mRNA expression or the secreted amount of IL-
6 was seen following treatment with GMG-43AC (Figure 2). The mechanism of this 
anti-inflammatory action of GMG-43AC involves a trans-repression of NF-kB 
signaling pathway (data not shown).  
The current pilot study shows that PPAR activation via GMG-43AC (Figure S1) 
represents an interesting novel hair growth-inhibitory strategy that constitutes a 
substantial advance over currently practiced therapies for managing undesired hair 
growth: Our results with this novel PPAR-modulator suggest that stimulating 
PPAR-signaling can effectively abrogate hair growth by premature catagen 
induction. While other hair growth-inhibitory compounds also promote catagen [e.g. 
tretinoin (Foitzik et al., 2005), eflornithine (Kloepper et al., 2010) or dopamine 
(Langan et al., 2013)], GMG-43AC appears to actually protect human HF epithelial 
stem cells, as indicated by its stimulatory effects on K15 and K19 protein expression 
and the number of K19+ cells.  
Along with the well-appreciated anti-inflammatory effects of PPAR agonists (here 
exemplarily demonstrated for GMG-43AC in cultured NHKs), this promises that 
PPAR-modulators like GMG-43AC may allow to optimize human hair growth 
inhibition by effectively suppressing unwanted hair growth by pushing anagen HFs 
into catagen while simultaneously preserving the HF’s epithelial progenitor cells pool. 
The latter appears important to maintain the HF and its stem cells as a regeneration 
resource for optimal skin wound healing (Plikus et al., 2012; Xiong et al., 2013). If 
applied together with standard depilatory therapies, the anti-inflammatory effects of 
PPAR-modulators like GMG-43AC may also reduce the pro-inflammatory sequelae 
of depilation. Together with its favorable toxicity profile (Pirat et al., 2012), this 
renders topically applied GMG-43AC an interesting candidate agent for clinical 
testing in the future management of hirsutism.  Moreover, the anti-inflammatory and 
candidate “stem cell-protective” properties of this PPARγ modulator also invite the 
future testing of GMG43-AC in cicatricial alopecia such as LPP [e.g., it is 
conceivable that GMG-43AC might inhibit LPP progression based on irreversible HF 
stem cell damage (Harries et al., 2013; Karnik et al., 2009)]. 
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Figure legends 
 
Figure 1. GMG-43AC enhances premature catagen, but stimulates keratins K15 
and K19. (a) Percentage of HFs in anagen, early, mid or late catagen. GMG43-AC 
administration induced catagen. (b) Hair cycle score, determined as previously 
described (s4). Higher score means catagen induction. Columns represent 
means±SEM; data were pooled from 5 independent experiments, n=54-71 HFs for 
each group. (c-d) GMG43-AC stimulated immunoreactivity of K15 (c) and K19 (d) in 
organ-cultured human scalp HFs. Staining intensities were measured in defined 
reference areas (white rectangles) using ImageJ software. Additionally, the number of 
K15- (c) and K19-positive (d) cells was counted relative to the total number of DAPI-
positive cells. Columns represent means±SEM; n=22-44 HFs/group. *P<0.05, 
**P<0.01, ***P<0.001; unpaired two-tailed Student's t-test.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Suppression of IL-6 in response to GMG-43AC. (a-b) mRNA transcript 
level of IL-6 evaluated by real time PCR in normal human keartinocytes (NHKs) 
stimulated with IFNγ (30ng/ml) and TNF-α (10ng/ml) in the presence of GMG-43AC 
(0.5 mM) for 6 h. Values are normalized to GAPDH and expressed relative to 
untreated cells. (c-d) IL-6 protein level measured by ELISA assay in NHKs 
supernatants treated with IFNγ (30ng/ml) and TNF-α (10ng/ml) in the presence of 
GMG-43AC (0.5 mM) for 24 h. Cytokine levels were measured in duplicates for each 
condition and expressed as pg/mg protein. Statistical significance between groups was 
assessed using paired Student’s t-test **P<0.01; ***P<0.001 vs Ctr ##P<0.01 vs 
stimulus. 
 
 
